InMed Pharmaceuticals GAAP EPS of -$0.44

November 06, 2025 05:57:57 pm

Source: SeekingAlpha

2025-11-06 17:57:57 ET

More on InMed Pharmaceuticals

Read the full article on Seeking Alpha

For further details see:

InMed Pharmaceuticals GAAP EPS of -$0.44

InMed Pharmaceuticals Inc.

NASDAQ: INM

INM Trading

123.81% G/L:

$1.555 Last:

73,877,530 Volume:

$1.79 Open:

VWAV Ad 300

INM Latest News

May 19, 2026 02:21:00 pm

/C O R R E C T I O N -- InMed Pharmaceuticals/

May 19, 2026 11:30:35 am

These Stocks are Riding Some of the Hottest Narratives on Wall Street

May 19, 2026 10:56:00 am

INM Stock Alert: Halper Sadeh LLC is Investigating Whether InMed Pharmaceuticals, Inc. is Obtaining a Fair Price for its Shareholders

May 19, 2026 08:00:00 am

InMed Pharmaceuticals & Mentari Therapeutics Announce Merger to Advance Migraine Prevention Therapies

INM Stock Data

Market Cap$2,888,312

Float2,780,350

Insiders Ownership4.07%

Institutions5

Short PercentN/A

IndustryPharmaceuticals

SectorHealthcare

Websitehttps://www.inmedpharma.com

CountryCA

CityVancouver

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App